All In MedTech

Device type · JIX

Calibrator, Multi-Analyte Mixture

FDA groups similar devices under a three-letter product code. This page gathers what FDA's public data says about JIX: how it is classified, what has been cleared or approved, and what has been reported and recalled.

Last checked: Nov 21, 2026Source: openFDAMethods & limitations

How FDA classifies it

Device type
Calibrator, Multi-Analyte Mixture
Product code
JIX
Device class
Class II
Review panel
Clinical Chemistry
Regulation
21 CFR 862.1150

Latest FDA decisions

All decisions for JIX

3 more FDA decisions with a free account

Adverse event reports received per month

By the date FDA received each report, stacked by event type. The newest month is incomplete.

Open in the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 232000
Jan 240000
Feb 244000
Mar 241000
Apr 241000
May 240000
Jun 240000
Jul 241000
Aug 243000
Sep 241000
Oct 242000
Nov 241100
Dec 240000
Jan 251000
Feb 252100
Mar 250000
Apr 255000
May 250000
Jun 251000
Jul 254000
Aug 250000
Sep 250000
Oct 251000
Nov 251000
Dec 252000
Jan 260000
Feb 264000
Mar 260000
Apr 260000
May 266000
Jun 261000
Jul 262000
Aug 260000
Sep 260100
Oct 262000
Nov 260000

Manufacturers named most often

Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.

The full in this ranking with a free account

Device problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • High Test Results11

3 more in this ranking with a free account

Patient problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • No Clinical Signs, Symptoms or Conditions19

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

  • Aniara Diagnostica LLC

    Z-2895-2026 · Started Jul 1, 2026 · Posted by FDA Aug 5, 2026

    Reason given: Stability issues with the reconstituted lyophilized human plasma and bivalirudin matrix have been identified. These stability issues lead to a degradation of measurable bivalirudin in the controls, calibrators, and linearity values.

    Cause as FDA categorized it: Process control

72 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.